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ABSTRACT - The prevalence of Schneiderian first-rank symptoms (FRS) in 294 
consecutive admissions to a research unit was evaluated with reference to their 
diagnostic distribution (SADWRDC). Thirty-five of 58 patients with schizophrenia 
had FRS, as compared to nine of 190 patients with major depressive disorder. All 
patients with two or more FRS received a diagnosis of schizophrenia. In the absence 
of organic or toxic etiology, the specificity of FRS for schizophrenia was 95% and 
their predictive value was 90%. These findings indicate that FRS should be regarded 
as strongly suggestive of schizophrenia in the absence of an organic syndrome. 
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Kurt Schneider (1) described eleven first-rank 
symptoms (FRS) which he suggested were patho- 
gnomonic of schizophrenia when undeniably 
present in the absence of an organic or toxic 
etiology. This assertion generated little interest 
(2) until the appearance in 1970 of Mellor’s exten- 
sive review of FRS (3) in which he concluded that 
“these symptoms offer an operational definition 
of schizophrenia which might be suitable for 
research purposes, particularly when a prior and 
exclusive selection of schizophrenic subjects must 
be made.” Schneiderian FRS have since become 
increasingly important in the diagnosis of schizo- 
phrenia and have been made an integral part of 
several standard structured interviews, such as 
the Present State Examination (4) and the Sched- 
ule for Affective Disorders and Schizophrenia 
( 5 ) .  They have also been introduced into widely 
used diagnostic systems, including the Research 
Diagnostic Criteria (RDC) (6) and DSM-I11 (7). 
However, even as the use of Schneiderian FRS in 
the diagnosis of schizophrenia has become more 
widespread, their specificity for schizophrenia 
has been diluted. DSM-111 and RDC both require 
that an affective syndrome first be excluded 
before the presence of FRS can indicate schizo- 
phrenia. FRS are thus no longer considered diag- 
nostic of schizophrenia in the absence of an 
organic etiology. 
The question of whether FRS consistently dis- 
tinguish between schizophrenia and major affec- 
tive disorder has generated considerable debate 
and there are major inconsistencies in the litera- 
ture with regard to this issue. Schneider (1) had 
claimed that “schizophrenia symptoms of first- 
rank importance have decisive weight beyond all 
others in establishing a differential typology be- 
tween schizophrenia and cyclothymia, and must 
have undisputed precedence when it comes to the 
allocation of the individual case.” This claim is 
supported by several studies that suggest that FRS 
have a high predictive value for schizophrenia. 
Wing & Nixon (8) noted that Schneiderian first- 
rank symptoms were associated with “nuclear 
schizophrenia” or “paranoid syndrome” in 95 9’0 
of cases. Mellor et al. (9) reported 88% temporal 
stability of a schizophrenic diagnosis made on 
the basis of FRS over an average follow-up 
period of 5 years. CoryelI (10) in an extensive 
family history and outcome study, found that 
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mood-congruent affective psychoses resembled 
non-psychotic affective disorders, while mood- 
incongruent affective psychoses resembled schi- 
zophrenia. Whalley et al. ( 1 1 )  reported an asso- 
ciation between increased growth hormone re- 
sponse to apomorphine (suggestive of dopamin- 
ergic hyperactivity) in schizophrenia only as 
defined by FRS, but not when other diagnostic 
schemes were used. Akiskal & Puzantian (12) 
reported that FRS in affectively ill patients were 
often secondary to  a concurrent drug psychosis 
and that in the differential diagnosis between 
schizophrenia versus affective psychosis, the spe- 
cificity of FRS for schizophrenia was 90% 
provided that any complicating medical condi- 
tions were excluded. On the other hand, FRS 
have been reported to  occur in over 15% of 
patients with affective psychoses (13-15). Some 
studies have reported the occurrence of FRS in 
affective psychoses defined by family history, 
treatment response, and course (16-19) Other 
studies have found that FRS have a poor predic- 
tive value for the various states that are assumed 
to be a consequence of schizophrenia (20-23). 
Pope & Lipinski (24), in an extensive review of 
the specificity of “schizophrenic symptoms”, 
concluded that no symptoms including Schneid- 
erian FRS had demonstrable specificity in diag- 
nosing schizophrenia. 
These discrepant findings prompted Mellor (25) 
to cautiously conclude that while “Schneider’s 
claims about first-rank symptoms find only lim- 
ited support from the more recent literature, those 
who find them of clinical value need not yet aban- 
don them”. The present study examined the preva- 
lence and diagnostic specificity of FRS in patients 
admitted to the Clinical Studies Unit for Affective 
Disorders between 1977 through 1984, in an effort 
to help resolve the uncertainty reflected in the 
literature regarding their utility as primary diag- 
nostic criteria. 
Method 
All admissions to  the 12-bed Clinical Studies 
Unit for Affective Disorders at the University of 
Michigan Medical Center between 1977 through 
1984 were reviewed for possible inclusion in the 
study. Patients were retained only if they had 
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294 50 18.9 
undergone a comprehensive SADS interview by a 
trained clinician in the course of the inpatient 
stay after having been off all medication for at 
least 2 weeks. These patients were screened for 
the presence of first-rank symptoms at the time 
of the baseline evaluation. Presence or absence 
of first-rank symptoms was established on the 
basis of the standardized SADS interview. The 
RDC diagnoses of all patients were reviewed and 
their clinical charts were scrutinized to determine 
the nature of treatment received. The prevalence 
of Schneiderian first-rank symptoms in the popu- 
lation of patients admitted to  the unit and the 
diagnostic distribution of patients with FRS was 
evaluated. The relative specificity and predictive 
value of first-rank symptoms for the diagnosis of 
schizophrenia was assessed. 
Results 
Over the 8-year period, 294 patients who met the 
criteria for inclusion in the study were admitted 
to the unit. Fifty of these patients exhibited one 
or more first-rank symptoms at the time of the 
baseline, drug-free SADS interview. The dis- 
tribution of the 294 patients according to the 
major diagnostic categories and the prevalence of 
FRS is shown in Table I .  
Among the 50 patients with FRS, 28 had one 
FRS, nine had two, five had three, four had four 
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Table 2 clincian was unable to make a differential diag- 
nosis with any degree of certainty between affec- 
tive disorder and either schizophreni-form disor- 
der or schizophrenia.) In view of the nebulous 
character of this category and the uncertainty of 
Audible thoughts 14 28 its nosologic status and relationship to schizo- 




First-rank symptom Percent age 
Voices arguing or 
discussing patient 9 
Voices commenting on 
patient’s activity 10 
Thought insertion 16 
Thought withdrawal 14 
Thought broadcast 13 
Made feelings-made impulses 8 
Made volition 10 
Somatic passivity 5 










FRS, two had five and two had six FRS respec- 
tively. No patient had more than six FRS. All 22 
patients with two or more FRS received a diag- 
nosis of schizophrenia. 
The relative frequency of each FRS in the 50 
patients with FRS is shown in Table 2 .  The 
prevalence of individual FRS in the 50 patients 
ranged from somatic passivity (five patients) to 
thought insertion (16 patients). The frequency of 
delusional perception could not be documented 
as it is not recorded as a specific symtom in the 
SADS. None of the FRS, analyzed individually, 
was found to be of significant value in discrimi- 
nating among the various diagnostic categories. 
While 35 of 58 patients (60.3%) with schizo- 
phrenia had FRS (see Table I), only nine of 190 
patients (4.7 Yo) with major depressive disorder 
(MDD) had one or more FRS (X2 = 129.32, df 
= 1, P < 0.001). When patients with secondary 
MDD with concurrent substance abuse and drug 
psychosis were excluded, only four of 171 
patients (2.3%) with primary MDD were found 
to  have FRS. Analysis of age, sex, and other 
demographic variables revealed that none of these 
factors was related to  the presence or absence of 
FRS in the various diagnostic categories. 
Six of the 23 patients with schizo-affective 
disorder had FRS. The status of this category is 
unclear. (According to DSM-111 this category 
was retained in the manual without diagnostic 
criteria only for those instances in which the 
phrenia and affective disorders, it has been 
excluded from further analysis. 
Thus, in the absence of an organic syndrome, 
the predictive value of FRS for schizophrenia 
was 90% (35 of 39). The specificity of FRS for 
schizophrenia as opposed to major affective dis- 
orders, was 97%. (Only four of the 176 primary 
affective disorder patients had FRS.) The sen- 
sitivity of FRS for schizophrenia was 60% (35 of 
58). 
All of the 35 schizophrenic patients with FRS 
were treated with neuroleptics; three of them 
additionally received a course of ECT. Of the 
four primary MDD patients with FRS, two were 
treated with a neuroleptic-antidepressant combi- 
nation while the other two were treated with a 
course of ECT followed by a neuroleptic-antide- 
pressant combination. Three of the six schizo- 
affective patients with FRS were treated with 
neuroleptics alone; two were treated with ECT 
and then maintained on neuroleptics, and one 
was treated with a neuroleptic-antidepressant 
combination. All five patients who had drug 
psychosis with secondary MDD and who showed 
FRS were briefly treated with a neuroleptic-anti- 
depressant combination. 
Discussion 
The high specificity and predictive value of first- 
rank symptoms for schizophrenia found in this 
study support Schneider’s belief that FRS, when 
present in the absence of an organic syndrome, 
almost invariably distinguish schizophrenia from 
affective disorders. Contrary to the work of vari- 
ous authors (13-15), FRS appeared in only 2% 
of patients with primary affective disorders. Our 
findings are in agreement with Akiskal & Puzan- 
tian (12) who concluded that Schneiderian symp- 
toms in affectively ill patients were often (five of 
nine in our study) secondary to  a concurrent 
organic or toxic state and that when the differen- 
tial diagnosis was made between schizophrenia 
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and affective psychosis, the specificity of FRS 
for schizophrenia exceeded 90% provided that 
concurrent medical conditions were excluded. 
The work of Mellor (3, 9) and Wing & Nixon (8) 
are also in accord with these findings. It should 
be noted that in our study the presence or 
absence of FRS was reliably established on the 
basis of a SADS interview administered by an 
experienced clinician. Some previous studies on 
FRS have been faulted on phenomenologic 
grounds (2, 26), which may account for discre- 
pancies between the present findings and those 
reported by other investigators. 
The sensitivity of FRS for schizophrenia in our 
sample was 6O%, a figure comparable to the 
57% obtained by Carpenter & Strauss (27) and 
intermediate between the 72% reported by 
Mellor (3) and the 51 070 reported by Carpenter et 
al. (13). 
In a review of the specificity of Schneiderian 
symptoms, Andreason & Akiskal (28) stated that 
the primacy of FRS for schizophrenia needed to  
be questioned because “the risk of tardive dys- 
kinesia is no longer acceptable in potentially 
lithium-responsive disorders.” None of the 50 
patients with FRS in our sample was treated with 
lithium, in contrast to 35 of the 244 patients 
without them. All the 50 patients with FRS 
received neuroleptics, while only ten received 
antidepressants additionally. This observation 
provides a somewhat crude treatment selection 
validation of the specificity of FRS for schizo- 
phrenia. 
Conclusion 
The 97% specificity and 90% predictive value of 
FRS for schizophrenia in our population, which 
contains over three times as many patients with 
primary affective disorders as patients with 
schizophrenia, suggests that the decision to  deny 
the specificity of FRS for the diagnosis of schizo- 
phrenia in the absence of an organic etiology 
may have been premature. We believe that an 
affective syndrome need not to  be ruled out if 
FRS are present, and that FRS should be 
regarded as strongly indicative of schizophrenia 
in the absence of an organic syndrome. 
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